Semax: Semax (Heptapeptide Nootropic)
Category: Cognitive & Neurological
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). Developed at the Institute of Molecular Genetics in Russia, it has been approved as a prescription nootropic in Russia and several former Soviet states since 2011. The peptide consists of seven amino acids with a modified C-terminus that improves its stability.
This guide compiles key literature themes, handling context, and practical comparison points for research-focused evaluation.
Overview
Researchers are particularly interested in Semax because of its pronounced effect on brain-derived neurotrophic factor (BDNF). Studies show it can increase BDNF expression substantially, which is significant because BDNF plays a central role in neuronal survival, learning, and memory formation.
Discovery & Background
Semax was developed over two decades by a team led by Nikolai Myasoedov at the Russian Academy of Sciences. The program began in the 1980s with the goal of creating a stable, non-hormonal peptide from the ACTH molecule that retained cognitive-enhancing properties without the endocrine effects. It received regulatory approval in Russia in 2011 for cognitive disorders and has been used clinically in several countries since.
Mechanism of Action
Semax enhances cognition primarily through upregulation of neurotrophic factors, modulation of monoamine neurotransmitter systems, and neuroprotective effects on brain tissue.
- 1Increases BDNF expression by 2-8 fold in hippocampal and cortical tissue
- 2Upregulates NGF (nerve growth factor) and TrkB receptor expression
- 3Modulates serotonin and dopamine metabolism in the brain
- 4Enhances acetylcholine signaling, which is critical for memory and attention
- 5Provides neuroprotection against oxidative stress and excitotoxicity
- 6Does not activate the HPA axis or produce cortisol elevation despite being derived from ACTH
Research Benefits
The benefit areas below reflect commonly discussed research interests for this peptide.
Cognitive Enhancement
Studies demonstrate improvements in attention, memory formation, and learning in both animal models and limited human research.
BDNF Upregulation
One of the most potent known stimulators of BDNF expression, a key neurotrophin for brain plasticity.
Neuroprotection
Research shows protective effects against ischemic brain damage and neurotoxin-induced injury.
Anxiolytic Properties
Some studies report anti-anxiety effects without sedation, possibly through serotonin modulation.
Published Research
BDNF Expression
Semax increased BDNF mRNA expression by 2-8 fold in rat hippocampus and cortex after a single administration.
Neuroscience Letters, 2006
Cognitive Function
Improved learning and memory retention in passive avoidance tests in rodents, with effects lasting 24 hours after administration.
Bulletin of Experimental Biology and Medicine, 2001
Stroke Recovery
Patients treated with Semax after ischemic stroke showed improved neurological recovery compared to controls in a clinical study.
Zhurnal Nevrologii i Psikhiatrii, 2005
Gene Expression
Semax modulated expression of over 100 genes in the brain, particularly those involved in neurotransmitter signaling and immune response.
BMC Genomics, 2014
Reported Side Effects & Considerations
- •Generally well-tolerated in published clinical use data from Russia
- •Mild nasal irritation when administered intranasally
- •Rare reports of headache at higher doses
- •No significant hormonal effects despite ACTH origin
Storage Guidelines
Temperature
2-8C refrigerated
Once Reconstituted
Use within 14 days when refrigerated
Shelf Life
24 months lyophilized at -20C
Frequently Asked Questions
What is Semax?
Semax is a synthetic heptapeptide derived from a fragment of ACTH (amino acids 4-10) with a modified C-terminus. It was developed in Russia as a cognitive enhancer and neuroprotective agent.
Is Semax approved anywhere?
Yes. Semax has been approved as a prescription medication in Russia and several former Soviet states since 2011 for cognitive disorders and stroke recovery.
How does Semax compare to Selank?
Both are Russian-developed peptides. Semax primarily targets cognition and BDNF expression, while Selank focuses more on anxiety reduction through GABA modulation. Some researchers study them in combination.
Does Semax have hormonal effects?
No. Despite being derived from ACTH, Semax does not activate the hypothalamic-pituitary-adrenal axis. It does not increase cortisol or have other endocrine effects at research doses.
How is Semax typically administered in research?
Most published studies use intranasal administration due to its bioavailability through nasal mucosa. This route also provides rapid access to the central nervous system.
Research Disclaimer
This guide is for educational and informational purposes only. All information is based on published scientific research and peer-reviewed literature. Peptides sold by Peptrolix are intended solely for laboratory research use and are not for human consumption. Consult healthcare professionals before making any health decisions.
Shop Semax
99%+ purity, lab-tested with certificate of analysis.
Review variant options and quantity pricing before adding to cart.
View SemaxBrowse All PeptidesRelated Peptide Guides
Related searches:
- semax
- semax peptide
- semax nootropic
- semax research
- semax cognitive
- semax bdnf
- semax neuroprotection
- semax vs selank
Explore More Peptide Guides
Explore adjacent compounds to compare mechanisms, side-effect discussions, and study focus across related peptides.
Start Your Research Today
All peptides 99%+ purity with certificates of analysis.
Products from Peptrolix are supplied strictly for laboratory and scientific research use only.
Shop Peptides